DESIGN DEVELOPMENT AND EVALUATION OF TRIMETAZIDINE DIHYDROCHLORIDE FLOATING BILAYER M.R TABLETS
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2011, Vol 2, Issue 7
Abstract
Modified release tablet are coated or uncoated tablet containing auxiliary substance or prepared by the procedure that, separately or together are design to modify the rate or place at which the active ingredient are released. Modified release (MR) DDS is an attempt to sustain drug blood concentration at relatively constant and effective level in the body by spatial placement or temporal delivery. Thus controlled release drug delivery system (CRDDS) offer various advantages viz. reduce blood level fluctuations, minimize drug accumulation, employ less total drug, improve patient compliance, and minimize local and systemic side effects.
Authors and Affiliations
Biswal Biswajit
EXPLORING PROTECTIVE ROLE OF MORIN ON PACLITAXEL-INDUCED LIPID PEROXIDATION USING MALONDIALDEHYDE AND 4-HYDROXY-2-NONENAL AS MODEL MARKERS
The present in vitro study was designed to explore antiperoxidative potential of morin on paclitaxel-induced lipid peroxidation. Goat liver tissue homogenate was used as source of lipid. Estimation of malondialdehyde and...
FORMULATION DEVELOPMENT OF ORO-DISPERSIBLE TABLETS OF AYURVEDIC POWDER FORMULATION FOR EFFICIENT USE
The aim of this study was to formulate mouth dissolving tablets from Ayurvedic polyherbal powder Sitopaladi. Sitopaladi is a traditional Ayurvedic powder preparation well known and effective in relieving coughs associate...
INDUSTRIAL PROCESS VALIDATION OF SOLID DOSAGE FORMS: A REVIEW
Validation is one of the important steps in achieving and maintaining the quality of the final product. If each step of production process is validated we can assure that the final product is of the best quality. Validat...
FORMULATION AND IN-VITRO EVALUATION OF TRAMADOL HYDROCHLORIDE FLOATING TABLETS
Tramadol hydrochloride is a synthetic opioid used as a centrally acting analgesic and effective in both experimental and clinical pain. The half-life of the drug is about 5.5 hours and oral dose is 50 to 100 mg every 4 t...
VETIVERIA ZIZANIOIDES (LINN.) NASH: A PHARMACOLOGICAL OVERVIEW
Vetiveria zizanioides is belonging to Poaceae family. It is well known plant from south India and widely distributed in India, Burma, Ceylon, and spread from Southwest Asia to tropical Africa. Vetiveria zizanioides is co...